Major shareholding disclosures from Renalytix and ActiveOps
UBS reported a 5.36% stake in Renalytix, and Octopus Investments a 16.07% stake in ActiveOps. Both notifications were disclosed on 19 October 2026.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
According to the Holding(s) in Company publication, UBS Group AG reported crossing the threshold in Renalytix PLC shares on 15 October 2026. On that date UBS held 35,912,299 voting rights, or 5.356372% of the issuer, with no financial instruments. The issuer notified the market on 19 October.
In the case of ActiveOps PLC, the notification came from Octopus Investments Limited, which crossed the threshold on 16 October 2026. Its stake rose from 15.98% to 16.07%, equal to 11,527,317 voting rights. The issuer published the notice on 19 October.
why it matters
Disclosures of this kind are required under UK rules and rarely move share prices on their own. For investors they show how large blocks change hands in smaller companies and can hint at institutional interest.
market impact
Renalytix and ActiveOps shares: informational effect, direct price impact usually limited
tags
instruments
sources
- REG - Renalytix PLC — Holding(s) in Company, 19 October 2026 at 12:15 UTC
- REG - ActiveOps PLC — Notification of Major Holdings, 19 October 2026 at 13:21 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗